option chains Fidelity
Home > Boards > US OTC > Biotechs >

Amarantus BioScience Holdings, Inc. (AMBS)

AMBS RSS Feed
Add AMBS Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator r00kie, Inoviorulez, joboggi, brickbybrick, Natural Treasures, longboardsurfer90210
Search This Board:
Last Post: 4/24/2014 2:58:22 AM - Followers: 649 - Board type: Free - Posts Today: 3

yes
 



(This "Intro Box" is NOT maintained by Amarantus BioScience, Inc. and is intended solely as a quick information source on ihub.  For more detailed, up-to-date information on Amarantus BioScience, Inc., please go the company website.)
 

Amarantus is a biotechnology company developing treatments and diagnostics for diseases associated with neurodegeneration and protein misfolding-related apoptosis. The company has licensed Eltoprazine, a Phase 2B ready Parkinsons Levadopa induced Dyskinesia. The company has an exclusive worldwide license to the Lymphocyte Proliferation test ("LymPro Test®") for Alzheimer's Disease and owns the intellectual property rights to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor ("MANF") and is developing MANF-based products as treatments for brain disorders. Amarantus is a Founding Member of the Coalition for Concussion Treatment (#C4CT), a movement initiated in collaboration with Brewer Sports International seeking to raise awareness of new treatments in development for concussions and nervous-system disorders. The Company also owns intellectual property rights for the diagnosis of Parkinson's Disease ("NuroPro") and the discovery of neurotrophic facotrs ("PhenoGuard"). For furtherinformation, please visit www.Amarantus.com, or connect with the company on Facebook, LinkedIn, Twitter and Google+.

Amarantus' Management Team and Board of Advisors have designed a business strategy to formulate and advance pre-clinical and clinical programs for the Company's product candidates through successive de-risking milestones in order to maximize their commercial potential. The Company is also focused on making the assets attractive partnering targets for product development focused biotechnology, pharmaceutical, medical device and diagnostic companies.

 
SHARE STRUCTURE
643,210,764 million shares oustanding as of March 6, 2014


TRANSFER AGENT
Stock Transfer, LLC
77 Spruce Street, Suite 201
Cedarhurst, NY 11516
Attention: Yoel Goldfeder
Phone: 212-828-8436
Toll-Free: 855-9VSTOCK
Fax: 646-536-3179



USEFUL LINKS:

DAILY CHART


EDGAR (SEC) FILINGS

PRESS RELEASES & NEWS ARTICLES


VIDEOS/AUDIO

Amarantus at LD Micro 6th Annual Conference, December 3, 2013

 



Medical Dictionary (some often-used terms in AMBS PRs)

The substania nigra is an area of pigmented cells in the midbrain which is responsible for producing the neurotransmitter dopamine. This section of the brain plays an important role in the control of movement, and it also appears to interact in the process of addiction, as well. If you view a brain in cross-section, the substantia nigra is located in the midbrain, right at the tip of the brainstem.

The striatum is also called the striate body. It includes the caudate nucleus and the lentiform nucleus. The term striatum (striate) refers to the layered appearance of bands of gray matter that course from one of these nuclei to the other and represent the connections between them.

In living tissues, reinnervation describes the process by which post-synaptic neurons form new synapses or increase existing synaptic efficacy in order to compensate for a lack of pre-synaptic input from dead or otherwise dysfunctional pre-synaptic neurons.


Glial cell-derived neurotrophic factor, also known as GDNF is a protein that, in humans, is encoded by the GDNF gene.[1] GDNF is a small protein that potently promotes the survival of many types of neurons.[2

Myocardial infarction (MI) or acute myocardial infarction (AMI), commonly known as a heart attack

---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Pertinent Terms of Service

A. Is unlawful, threatening, abusive, harassing, defamatory, libelous, vulgar, hateful, deceptive, fraudulent, invasive of another's privacy, tortious, contains explicit or graphic descriptions or accounts of sexual acts (including but not limited to sexual language of a violent or threatening nature directed at another individual or group of individuals), or otherwise violates our rules or policies; This includes signatures as well. 
B. Attacks, verbally or otherwise, any other user, the website, any non-public figure, or any agents or employees of iHub; This includes signatures as well. 
C. Victimizes, harasses, degrades, or intimidates an individual or group of individuals on the basis of religion, gender, sexual orientation, race, ethnicity, age, or disability; This includes signatures as well. 

 




  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AMBS
Current Price
Volume:
Bid Ask Day's Range
Wiki
AMBS News: Amarantus Announces 2013 Year End Financial Results 04/21/2014 08:30:00 AM
AMBS News: Annual Report (10-k) 04/21/2014 06:56:28 AM
AMBS News: Amarantus Appoints Dr. Charlotte Keywood Chief Medical Officer of Its Therapeutics Division 04/08/2014 06:00:00 AM
AMBS News: Amarantus Appoints Robert Farrell, J.D. as Chief Financial Officer 04/01/2014 06:00:00 AM
AMBS News: Amarantus Appoints Dr. Louis Kirby to Board of Advisors 03/31/2014 08:30:00 AM
PostSubject
#98701  Sticky Note AMBS is holding its own. Natural Treasures 04/03/14 09:12:30 PM
#94873  Sticky Note Current Milestones & Catalysts brickbybrick 02/10/14 03:46:28 PM
#93343  Sticky Note Amarantus CEO intends to up-list to a national WarpCore61 01/22/14 07:36:31 PM
#91837  Sticky Note Gerald continues to deliver! His blog set the gipper 01/13/14 09:56:07 PM
#74467  Sticky Note MJFF is firm with their notion that NFs joboggi 05/22/13 11:25:08 PM
#53611  Sticky Note SECOND BOARD WARNING! IH Admin [Dan] 02/02/13 05:38:48 PM
#99910   Thanks Warp TekNerd 04/24/14 02:58:22 AM
#99909   Conference Call Information WarpCore61 04/24/14 02:25:40 AM
#99908   Could someone post details for the update call TekNerd 04/24/14 02:21:56 AM
#99907   Joboggi, in my opinion your news is no sante1 04/23/14 11:43:32 PM
#99906   The paperwork is being filed as we speak Nolan 11 04/23/14 10:39:01 PM
#99905   So when do think ambs will declare bankruptcy? Angry Goat 04/23/14 10:07:23 PM
#99903   Standard jargon, financial warnings in all small companies. breezy1 04/23/14 09:55:02 PM
#99902   "Wow, this is totally news to me, I Tanis2476 04/23/14 09:50:41 PM
#99901   I will post investor conference call audio files WarpCore61 04/23/14 09:37:59 PM
#99900   That is why biotechs tend to return to joboggi 04/23/14 09:25:33 PM
#99899   WarpCore61 04/23/14 09:21:32 PM
#99898   The joke is on you guys, there is joboggi 04/23/14 09:11:54 PM
#99897   I was thinking the same thing. TekNerd 04/23/14 08:49:26 PM
#99896   I guess all the new hires will be r00kie 04/23/14 08:42:00 PM
#99895   Lol AMBS still has a valid operational license zoomboom 04/23/14 08:26:18 PM
#99894   The accompanying financial statements have been prepared in joboggi 04/23/14 08:14:07 PM
#99889   I don't think the conference will move it Inoviorulez 04/23/14 05:40:30 PM
#99887   Hoping for the conference as a catalyst to orion1983 04/23/14 04:58:32 PM
#99886   Since I only have one post per day, jeffshir 04/23/14 04:53:10 PM
#99885   Note to Desolation Row: "No one cares." Solantey 04/23/14 04:52:09 PM
#99884   This is perfect, just what we want in breezy1 04/23/14 04:27:09 PM
#99883   Toxic Financing and Dilution Magna/Hanover MUST READ Desolation Row 04/23/14 03:56:20 PM
#99882   Toxic Financing and Dilution IRONRIDGE WARNING! Desolation Row 04/23/14 03:56:05 PM
#99881   Beware! Toxic Financing and Dilution ASHER ENTERPRISES Desolation Row 04/23/14 03:55:49 PM
#99880   Quarterly losses up nearly 400% year to year. Desolation Row 04/23/14 03:55:26 PM
#99879   TOXIC Financer DOMINION adds nearly 5% to ownership. Desolation Row 04/23/14 03:55:05 PM
#99878   MORE Dominion TOXIC FINANCING: Desolation Row 04/23/14 03:54:52 PM
#99877   AMBS Net loss UP 300% over 2012. Desolation Row 04/23/14 03:54:40 PM
#99876   Your link was messed up. Here's the same WarpCore61 04/23/14 03:40:59 PM
#99875   Interesting post - mui bueno JPetroInc 04/23/14 03:08:17 PM
#99874   That's what I took away from it. jembers 04/23/14 03:00:06 PM
#99873   yes, thanks jembers for digging that up...that's the lighter than AIR 04/23/14 02:52:43 PM
#99872   Wow, I take a trip to Ottawa for JJAAMMAANN 04/23/14 01:49:39 PM
#99871   Okay, that seems to indicate we had some WarpCore61 04/23/14 12:46:17 PM
#99870   This is what was written: jembers 04/23/14 12:43:06 PM
#99869   Perhaps. I don't recall reading that post. WarpCore61 04/23/14 12:34:57 PM
#99868   don't have time to look back now...but pretty lighter than AIR 04/23/14 12:33:36 PM
#99867   Gerald had 2 tweets on April 17 regarding WarpCore61 04/23/14 12:31:38 PM
#99866   Didn't Gerald pretty much indicate that in one lighter than AIR 04/23/14 12:27:30 PM
#99865   Regarding the late filing status, I've been checking WarpCore61 04/23/14 12:10:37 PM
#99864   Those who have done proper dd understand the jembers 04/23/14 10:31:26 AM
#99863   Yes great buying time here. When its %300 breezy1 04/23/14 10:30:21 AM
#99862   I don't mind all this selling gives me Inoviorulez 04/23/14 10:25:56 AM
#99860   Thank You DOMINION and LINCOLN. You believe in gulf shores man 04/23/14 10:22:18 AM
#99859   My main concern regarding dilution is that we Calm68 04/23/14 10:19:15 AM
#99858   dsw, if you want I can submit your breezy1 04/23/14 10:18:12 AM
#99857   go away or I"ll contact the authorities. dsw 04/23/14 09:48:35 AM
#99854   TOXIC Financer DOMINION adds nearly 5% to ownership. Desolation Row 04/23/14 09:36:30 AM
#99853   MORE Dominion TOXIC FINANCING: Desolation Row 04/23/14 09:36:16 AM
#99852   AMBS Net loss UP 300% over 2012. Desolation Row 04/23/14 09:36:05 AM
PostSubject